novo nordisk fda semaglutide Nordisk's weight-loss pill wins approval Novo Nordisk takes legal action

Laboratory results revealed acidosis with a pH of 7.34, elevated anion gap, beta-hydroxybutyrate, severe hypokalemia, hypophosphatemia, and acute kidney injury

pylori easily develops antibiotic resistance through gene mutation, leading to a significant decrease in eradication rates

it has a half-life of 11 minutes and requires 3 injections per day

Side effects: Some people experience nausea or diarrhea with semaglutide

PubMed laboratory research record [PMID: 38004420] PubMed record related to this compound for laboratory literature review

No, there is no established direct causal link between Wegovy (semaglutide) and kidney stone formation based on clinical trial data and post-marketing surveillance